|
TOP STORY |
Enrichment of Autologous Fat Grafts with Ex-Vivo Expanded Adipose Tissue-Derived Stem Cells for Graft Survival: A Randomized Placebo-Controlled Trial Researchers report the results of a triple-blind, placebo-controlled trial to compare the survival of fat grafts enriched with autologous adipose-derived stem cells versus non-enriched fat grafts. [The Lancet] Abstract | Press Release |
PUBLICATIONS (Ranked by impact factor of the journal) |
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation CMX001 has potent in vitro activity against cytomegalovirus (CMV) and other double-stranded DNA viruses. Researchers evaluated the safety and anti-CMV activity of CMX001 in patients who had undergone allogeneic hematopoietic-cell transplantation. [N Engl J Med] Abstract | Press Release RNAi-Mediated Silencing of Myc Transcription Inhibits Stem-Like Cell Maintenance and Tumorigenicity in Prostate Cancer Hypoxia-Induced Therapeutic Neovascularization in a Mouse Model of an Ischemic Limb Using Cell Aggregates Composed of HUVECs and cbMSCs Umbilical Cord and Bone Marrow Mesenchymal Stem Cell Seeding on Macroporous Calcium Phosphate for Bone Regeneration in Rat Cranial Defects Serial Transplantation and Long-Term Engraftment of Intraarterially Delivered Clonally-Derived Mesenchymal Stem Cells to Injured Bone Marrow Cardiac Stem Cells with Electrical Stimulation Improve Ischemic Heart Function through Regulation of Connective Tissue Growth Factor and miR-378 The In Vitro and In Vivo Effects of a Low-Molecular-Weight Fucoidan on the Osteogenic Capacity of Human Adipose-Derived Stromal Cells Direct Comparison of Autologous and Allogeneic Transplantation of iPSC-Derived Neural Cells in the Brain of a Nonhuman Primate Autologous Transplantation of GDNF-Expressing Mesenchymal Stem Cells Protects against MPTP-Induced Damage in Cynomolgus Monkeys |
REVIEWS |
Pluripotent Reprogramming and Lineage Reprogramming: Promises and Challenges in Cardiovascular Regeneration Researchers review the landmark progresses of two major reprogramming strategies, pluripotent reprogramming and lineage reprogramming, compare their pros and cons in cardiovascular regeneration, and forecast the future directions of cardiac repair. [Tissue Eng Part B Rev] Abstract Visit our reviews page to see a complete list of reviews in the cell, gene and immunotherapy research field. |
SCIENCE NEWS |
Bioheart Announces Positive Preliminary Data from Phase I ANGEL Trial Bioheart, Inc. announced preliminary data from its Phase I ANGEL Trial. Fully funded by Bioheart, the trial is being conducted in Mexico at the Hospital Angeles in conjunction with the Regenerative Medicine Institute. This Phase I study will provide necessary safety and preliminary efficacy of adipose derived stem cells (AdipoCellTM) in patients with congestive heart failure. [Bioheart Inc.] Press Release |
POLICY |
House Science Committee Drafts Controversial Bill on U.S. Research Funding A key congressional committee is planning a hearing next month on legislation that could give several U.S. science agencies new marching orders. The details are still a secret, but expect fireworks. The legislation has been drafted by the Committee on Science, Space, and Technology in the U.S. House of Representatives. [Committee on Science, Space, and Technology, United States] Press Release NIH Swears Off Science Education From our sponsor: Free wallchart from Nature Neuroscience – Neural Stem Cells. Request your copy. |
BUSINESS |
Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem Cells Bioheart, Inc. announced that it has entered into an agreement with Invitrx Therapeutics to license their adipose derived stem cell products. The license agreement term sheet for adipose derived cells is for use in all indications in both human and animal medicine. [Bioheart, Inc.] Press Release BioLife Solutions and SAVSU Technologies Announce Exclusive Distribution Agreement Disease-Specific Human Embryonic Stem Cell Lines Placed on NIH Registry SpinalCyte, LLC Receives Australian Patent for Spinal Disc Tissue Engineering Arteriocyte Awarded BARDA Contract Valued up to $101.1 Million for Advanced Development of Arteriocyte’s Magellan® BioBandageTM for Thermal Radiation Injury National Cancer Institute Awards $48.6 Million Grant to MD Anderson McGowan Institute Will Co-Direct $75 Million Second Phase of National Effort to Aid Wounded Warriors Canadian Stem Cell Technology Expected to Offer New Options for Blood Stem Cell Transplants Gaharwar Co-Edits Biomedical Textbook |
REGULATORY |
Food and Drug Administration (United States) |
EVENTS |
NEW StemCore and Cell Reprogramming Australia 2013 iPS Cell Training Workshop Brisbane, Australia October 30-November 1, 2013 Visit our events page to see a complete list of events in the cell, gene and immunotherapy community. |
SUBSCRIBER TOOLS: | |||
Profile Center | Connexon Publications | Article Submission | Contact Us |